- Report
- August 2024
- 250 Pages
Global
From €4133EUR$4,450USD£3,458GBP
- Report
- July 2025
- 114 Pages
Global
From €3500EUR$4,036USD£3,031GBP
- Report
- May 2025
- 90 Pages
Global
From €3500EUR$4,036USD£3,031GBP
- Report
- January 2025
- 106 Pages
Global
From €3500EUR$4,036USD£3,031GBP
- Report
- September 2025
- 150 Pages
Global
From €4505EUR$4,850USD£3,769GBP
- Report
- September 2025
- 150 Pages
Global
From €4505EUR$4,850USD£3,769GBP
- Report
- September 2025
- 150 Pages
Global
From €4505EUR$4,850USD£3,769GBP
- Report
- June 2025
- 150 Pages
Global
From €4505EUR$4,850USD£3,769GBP
- Report
- March 2025
- 150 Pages
Global
From €4505EUR$4,850USD£3,769GBP
- Report
- October 2025
- 91 Pages
Middle East
From €4180EUR$4,500USD£3,497GBP
The Multiplex Sequencing market is a subset of the genomics industry that focuses on the sequencing of multiple DNA samples simultaneously. This technology is used to analyze the genetic makeup of a sample, such as a tumor, to identify mutations or other genetic changes. Multiplex sequencing is also used to study the genetic diversity of a population, to identify genetic markers associated with disease, and to develop new diagnostic tests.
Multiplex sequencing is a rapidly growing field, with many companies offering products and services. These include Illumina, Thermo Fisher Scientific, Pacific Biosciences, Oxford Nanopore Technologies, 10x Genomics, and BGI Genomics. Show Less Read more